Biotech · Private company
Glyscend, Inc.
Track this companyFree. Adds Glyscend, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- GLY-200Phase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- GLY-200Phase 2 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With ObesityPHASE2 · COMPLETED · started May 20, 2024ClinicalTrials.gov NCT06259981 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic PatientsPHASE2 · COMPLETED · started Aug 3, 2022ClinicalTrials.gov NCT05478525 · fetched Nov 12, 2026